ENTITY

Jiangsu Hengrui Pharmaceuticals (1276 HK)

148
Analysis
Health CareChina
Jiangsu Hengrui Pharmaceuticals Co.,Ltd develops, manufactures, and markets medicines and medicine packing materials. The Company produces anti-tumor medicines, pain-killers, anti-infection medicines, aluminum foils, and other related products. Jiangsu Hengrui Pharmaceuticals conducts business in China, America, Japan, Korea, Europe, and Australia.
more
26 May 2025 08:08

ECM Weekly (26 May 2025) - CATL, Hengrui, Eastroc, Haitian, Schloss, Aegis, Hyundai Marine, Pony

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Logo
473 Views
Share
23 May 2025 09:10

China Healthcare Weekly (May.18) - Trump to Lower US Drug Prices, Thoughts on Hengrui's IPO Pricing

Hengrui's HK IPO debut is strong, driven by positive sentiment for AH listing and the small IPO size (225 million circulating shares). Investors...

Logo
720 Views
Share
21 May 2025 09:48

Eastroc Beverage A/H Listing - Energized - Fast Growth, Better Margins

Eastroc Beverage Group (605499 CH) (EB), a China-based functional beverage company, aims to raise around US$1bn in its H-share listing. In this...

Logo
479 Views
Share
18 May 2025 14:38

Weekly Deals Digest (18 May) - CATL, Hengrui, ESR, OneConnect, Mayne, Nissin, Nippon Road, TechnoPro

A weekly summary of key developments across ECM and Event-Driven names tracked by us across Hong Kong, Australia, NZ, Singapore, Japan, Indonesia,...

Logo
497 Views
Share
bullishPop Mart
16 May 2025 06:57

FXI Rebalance Preview: Pop Mart (9992 HK) Pops Up Again

Pop Mart could replace China Railway in the FXI ETF. Pop Mart is also a potential inclusion to other indices. Shorts have been increasing in both...

Logo
664 Views
Share
x